Use of sodium meta arsenite in the manufacture of an oral dosage form of a pharmaceutical composition for the treatment of non-cancer associated inflammation in a mammal and a kit comprising same

摘要

The present invention relates to the use of arsenic compounds such as sodium meta arsenite (NaAsO2), arsenic trioxide (As2O3), and arsenic hexoxide (As4O6) or combinations thereof, for the treatment of painful, hyperalgesic and/or inflammatory conditions. The present invention also relates to compositions containing the above arsenic compounds for use in the treatment of pain, inflammation and immunological and autoimmune diseases and disorders.